| Purpose | Announcement Date | Meeting Date |
|---|---|---|
| EGM | 16 Jan 2026 | 9 Feb 2026 |
| Notice of Extra Ordinary General Meeting of Sun Pharma Advanced Research Company Limited With reference to the Notice of Extra Ordinary General Meeting dated January 14, 2026, which was dispatched on January 16, 2026, the Company has issued a Clarificatory Corrigendum to the shareholders, which is enclosed herewith for your record and dissemination. (As Per BSE Announcement Dated On : 29.01.2026) Proceedings of the Extra Ordinary General Meeting of the Company held on February 09, 2026 (As Per BSE Announcement Dated on:09.02.2026) Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Addendum to the Valuation Report (As per BSE Announcement dated on: 24.02.2026) | ||
At the operating level, the EBITDA loss amounted to ₹102.9 Crore, a worsening from a loss of ₹91.4 Crore in the previous fiscal quarter.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
